“I believe this is the first time this has happened in the history of cancer.”

Results from a small cancer trial that left every patient in remission is being praised as “unprecedented” and “remarkable.” A paper published on Sunday at The New England Journal of Medicine outlined a study of 18 rectal cancer patients who were given dostarlimab every three weeks for six months and ended up cancer-free, including the first patient who is now two years out from the trial.

https://citizenfreepress.com/breaking/remarkable-breakthrough-in-cancer-research/